BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7686813)

  • 1. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
    Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
    J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
    Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
    Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
    Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
    Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
    Gould VE; Koukoulis GK; Virtanen I
    Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection.
    Gould VE; Martinez-Lacabe V; Virtanen I; Sahlin KM; Schwartz MM
    Lab Invest; 1992 Jul; 67(1):71-9. PubMed ID: 1378105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
    Jones JL; Critchley DR; Walker RA
    J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies.
    Assad L; Schwartz MM; Virtanen I; Gould VE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(5):307-16. PubMed ID: 7685961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the alpha v subfamily of integrins and their putative ligands in synovial lining cell layer.
    Nikkari L; Haapasalmi K; Aho H; Torvinen A; Sheppard D; Larjava H; Heino J
    J Rheumatol; 1995 Jan; 22(1):16-23. PubMed ID: 7535359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin expression on normal and neoplastic human breast epithelium.
    Damjanovich L; Fülöp B; Adány R; Nemes Z
    Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
    Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
    Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
    Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
    Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer.
    D'Ardenne AJ; Richman PI; Horton MA; Mcaulay AE; Jordan S
    J Pathol; 1991 Nov; 165(3):213-20. PubMed ID: 1662264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
    Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential.
    Jones JL; Royall JE; Critchley DR; Walker RA
    Exp Cell Res; 1997 Sep; 235(2):325-33. PubMed ID: 9299156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of beta 1, alpha 2 and alpha 3 subunits of VLA integrins in malignant mammary tumours.
    Pignatelli M; Hanby AM; Stamp GW
    J Pathol; 1991 Sep; 165(1):25-32. PubMed ID: 1659627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin expression in normal and abnormal human endometrium.
    Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
    Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.
    Tiitta O; Wahlström T; Paavonen J; Linnala A; Sharma S; Gould VE; Virtanen I
    Am J Pathol; 1992 Oct; 141(4):907-13. PubMed ID: 1384340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistological localization of cell adhesion proteins and integrins in the periodontium.
    Steffensen B; Duong AH; Milam SB; Potempa CL; Winborn WB; Magnuson VL; Chen D; Zardeneta G; Klebe RJ
    J Periodontol; 1992 Jul; 63(7):584-92. PubMed ID: 1380547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion systems in normal breast and in invasive breast carcinoma.
    Glukhova M; Koteliansky V; Sastre X; Thiery JP
    Am J Pathol; 1995 Mar; 146(3):706-16. PubMed ID: 7887451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
    Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
    Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.